Ligne de temps

Zhi Li
																												Ingénieur(e) de Recherche
																	06 déc. 2023
								publication
									Tick-borne flavivirus NS5 antagonizes interferon signaling by inhibiting the catalytic activity of TYK2.
Lire plus09 août 2023
								
							22 juin 2023
								project
									COVID-19-popCell – Genetic and infectious factors underlying population variability in immune responses to SARS-CoV-2
Lire plus01 janv. 2022
								publication
									IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation.
Lire plus01 janv. 2020
								publication
									Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.
Lire plus11 mars 2019
								
							21 déc. 2018
								publication
									Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common missense variant
Lire plus06 févr. 2017
								publication
									STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling
Lire plus20 juin 2016
								publication
									Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome
Lire plus19 mai 2016
								
							29 avr. 2016
								publication
									The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells
Lire plus15 sept. 2015
								
							15 sept. 2015
								
							11 mai 2015